About two-thirds of our patients also had psoriasis, though mostly minimal disease (Table 1), and therefore we cannot distinguish the immune consequences of inflammatory joint from inflammatory skin disease, nor determine to which inflammatory site the IL-22+ cells would be directed toward. The gene discussed is IL22; the disease is inflammatory skin disease.